Fund Holdings — GREAT POINT PARTNERS LLC

Total Portfolio Value
$212.20M
Total Bought
$40.23M
Total Sold
$149.81M
Net Transaction
-$109.57M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
XENON PHARMACEUTICALS INC(XENE)0245,272+245,27209,6154.53%+9,615
IONIS PHARMACEUTICALS INC(IONS)255,000505,007+250,00710,21517,6558.32%+7,440
UNICYCIVE THERAPEUTICS INC8,559,00010,980,000+2,421,0003,4918,7204.11%+5,229
UPSTREAM BIO INC(UPB)0300,000+300,00004,9322.32%+4,932
MEREO BIOPHARMA GROUP PLC(MREO)01,150,000+1,150,00004,0251.90%+4,025
REZOLUTE INC(RZLT)0621,894+621,89403,0471.44%+3,047
OPTINOSE INC0370,269+370,26902,4731.17%+2,473
JASPER THERAPEUTICS INC(JSPR)322,380322,38006,0646,8923.25%+829
CYTOKINETICS INC(CYTK)316,000360,000+44,00016,68516,9347.98%+250
KALVISTA PHARMACEUTICALS INC1,299,5031,787,003+487,50015,04815,1367.13%+88
HELIX ACQUISITION CORP II500,000500,00005,2255,2502.47%+25
VOYAGER THERAPEUTICS INC(VYGR)959,953826,751-133,2025,6164,6882.21%-928
PROMIS NEUROSCIENCES INC2,790,6982,645,128-145,5703,4882,5071.18%-981
ELIEM THERAPEUTICS INC(CLYM)248,1680-248,1681,2630—-1,263
DIANTHUS THERAPEUTICS INC(DNTH)275,000275,00007,5305,9952.83%-1,534
VISTAGEN THERAPEUTICS INC(VTGN)674,0750-674,0752,0290—-2,029
VIRIDIAN THERAPEUTICS INC(VRDN)750,000750,000017,06314,3786.78%-2,685
AUTOLUS THERAPEUTICS PLC(AUTL)2,811,9553,009,392+197,43710,2077,0723.33%-3,135
CARTESIAN THERAPEUTICS INC(RNAC)200,0000-200,0003,2240—-3,224
DYNAVAX TECHNOLOGIES CORP1,326,234860,000-466,23414,77410,9825.18%-3,792
TSCAN THERAPEUTICS INC(TCRX)1,016,3750-1,016,3755,0620—-5,062
ZURA BIO LTD(ZURA)3,263,6723,170,194-93,47813,2517,9253.73%-5,325
MERUS N V250,000158,092-91,90812,4906,6483.13%-5,842
OUTLOOK THERAPEUTICS INC(OTLK)1,293,0280-1,293,0286,9050—-6,905
PLIANT THERAPEUTICS INC(PLRX)1,910,1211,055,000-855,12121,41213,8946.55%-7,518
UROGEN PHARMA LTD(URGN)758,786187,843-570,9439,6372,0010.94%-7,636
ORUKA THERAPEUTICS INC(ORKA)514,659228,803-285,85612,6144,4362.09%-8,178
ARCELLX INC
COMMON STOCK
100,0000-100,0008,3510—-8,351
OPTINOSE INC12,861,1360-12,861,1368,6170—-8,617
CONTEXT THERAPEUTICS INC(CNTX)6,934,9824,683,711-2,251,27113,5934,9182.32%-8,675
EVOLUS INC(EOLS)1,170,000895,524-274,47618,9549,8874.66%-9,067
OLEMA PHARMACEUTICALS INC(OLMA)1,000,0000-1,000,00011,9400—-11,940
ABIVAX SA(ABVX)2,128,7731,648,523-480,25024,52312,0675.69%-12,456
NEUROGENE INC(NGNE)1,004,291442,761-561,53042,14010,1224.77%-32,019
Page 1 of 1
GREAT POINT PARTNERS LLC — 13F Holdings — Q4 2024 | TickerTrail